Satellos Bioscience Inc. (MSLE) AI Dilution Summary

Satellos reported cash of $61,839,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $2,935,500. Its funding facility is an active at-the-market (ATM) program with Leerink Partners LLC, authorised to $50,000,000. The largest price-linked source of dilution is the F-10 shelf registration 333-298223.